bioMérieux Canada, Inc.

What bioMérieux Canada, Inc. does

bioMérieux Canada, Inc. is the Canadian operating subsidiary of bioMérieux S.A., a French-headquartered, Euronext Paris-listed multinational specializing in in-vitro diagnostics. From its office in St-Laurent, Quebec, the Canadian entity has been present in the Canadian market for more than 30 years, serving healthcare providers — including hospitals, laboratories, and medical clinics — with diagnostic products and solutions intended to enable rapid, precise, and optimized patient care and to support public health objectives. The subsidiary operates as a national commercial and distribution arm rather than an independent product builder, with its portfolio effectively inherited from and integrated with the global bioMérieux group.

The company's offering in Canada is distributed through two principal channels: a direct enterprise sales motion (phone, email, and field contact for institutional buyers) and the bioMérieux+ e-commerce platform (eshop.biomerieux.com), which enables online ordering of bioMérieux products. Customer-facing marketing and engagement are supported by a localized innovation blog (biomerieuxinnovation.ca), press releases, and the parent group's social media presence (Facebook, LinkedIn, Instagram, YouTube). The subsidiary is also formally linked into the broader bioMérieux ecosystem, including affiliated brand BioFire Diagnostics (molecular diagnostics) and the global Resource Center, giving Canadian customers access to integrated diagnostic offerings.

Business model mechanics (pricing, contract structures, revenue per instrument or test, and margin profile) are not publicly disclosed on the Canadian site — buyers are directed to contact sales for pricing. Detailed product-level SKUs, instruments, and reagent menus are likewise not enumerated at the subsidiary level; the site points users to "Notre offre" and broader group resources. Consequently, financial figures specific to bioMérieux Canada are not available, and the entity should be assessed primarily through its role as a national sales/distribution subsidiary of a global diagnostics group.

Name

bioMérieux Canada, Inc.

Legal name

bioMérieux Inc. Canada

Website

https://biomerieux.ca

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

bioMérieux Canada, Inc. is the Canadian subsidiary of French multinational diagnostics company bioMérieux S.A., distributing in-vitro diagnostic products and solutions to Canadian hospitals, laboratories, and medical clinics from its St-Laurent, Quebec office via direct sales and the bioMérieux+ e-commerce platform.

Ownership category

akta.pro rank

Product category

In Vitro Diagnostics

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

SIC

In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Microbiology & Infectious Disease Diagnostics (culture, rapid antigen, syndromic panels) (HLAAALAC)

akta.pro secondary industry

Microbiology & Infectious Disease Testing (Trial Support) (HLAGAEAF)

Keywords

• In vitro diagnostics
• Clinical microbiology
• Molecular diagnostics
• Diagnostic testing solutions
• Medical laboratory equipment

Headquarters

HQ city

Saint Laurent

HQ country

Canada

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales

Distribution channels2 records

Marketing channels4 records

Core offering

bioMérieux Canada, Inc. is the Canadian subsidiary of bioMérieux S.A., selling innovative in vitro diagnostic solutions and clinical microbiology products to Canadian healthcare providers. The company supplies diagnostic testing products and reagents that enable rapid, precise, and optimized care for hospitals, laboratories, and medical clinics, supported by molecular diagnostics capabilities from affiliated BioFire Diagnostics. Customers access offerings through direct sales engagement and the bioMérieux+ online ordering platform.

Product overview

bioMérieux is a diagnostics company described as 'PIONEERING DIAGNOSTICS.' The Canadian subsidiary offers innovative solutions for rapid, precise, and optimized healthcare. The company provides access to bioMérieux+, an e-commerce platform, and maintains a blog (bioMérieux Innovation) covering industry topics. The broader portfolio includes BioFire Diagnostics (a related brand linked externally), educational resources, and an e-shop for product access. The specific product portfolio is referenced through navigation to 'Notre offre' (Our Offering) and 'Living Diagnostics' content areas, though detailed individual product/module listings are not present in the provided source content.

Differentiator

Problem solved

Functional benefit

Brands

• bioMérieux Innovation Blog: Blog platform for bioMérieux Canada innovation content
• bioMérieux+

Products and services

• bioMérieux+ E-commerce Platform

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Two partnerships are on record, tiered core and minor.

• BioFire DiagnosticscoreTechnology or IntegrationAffiliated company under the bioMérieux group specializing in molecular diagnostics. Part of the integrated bioMérieux ecosystem of diagnostic solutions.
• Resource Center bioMérieuxminorOthersCentralized resource hub for bioMérieux products, educational materials, and technical documentation supporting customers and partners.

Scale indicators1 record

Recent moves4 records

Expansion highlights4 records

Direct peers

• Hologic Canada: Hologic Canada competes in molecular diagnostics for women's health and infectious diseases. Overlapping molecular menu and shared target customer base (hospital labs) make it a relevant peer.
• Bio-Rad Laboratories Canada: Bio-Rad Canada provides quality controls, infectious disease testing, and digital PCR systems that compete with bioMérieux's microbiology and molecular product lines in Canadian lab settings.
• Siemens Healthineers Canada: Siemens Healthineers Canada competes in clinical chemistry, immunoassay, and laboratory automation. Comparable customer profile and broad menu offering create direct overlap in mid-to-large hospital lab contracts.
• Abbott Diagnostics Canada: Abbott's Canadian diagnostics division offers competing immunoassay, chemistry, molecular, and point-of-care platforms. Overlapping portfolio and similar customer base (hospital labs, provincial health authorities) make it a primary competitor.
• Beckman Coulter Canada: Beckman Coulter (Danaher) competes with bioMérieux in clinical chemistry, immunoassay, and microbiology workflows. Has meaningful Canadian lab presence and overlapping procurement relationships.
• BD (Becton Dickinson) Canada: BD Canada provides microbiology identification/AST systems (BD Phoenix, BD MAX) and pre-analytical specimen processing that compete directly with bioMérieux's VITEK and molecular platforms in Canadian laboratories.
• QuidelOrtho Canada: QuidelOrtho (post-merger of Quidel and Ortho Clinical Diagnostics) competes in immunoassay, rapid diagnostics, and blood banking. Some overlap with bioMérieux in the Canadian hospital lab market.
• Roche Diagnostics Canada: Canadian arm of Roche Diagnostics, the world's largest IVD company. Directly competes with bioMérieux across clinical chemistry, immunoassays, molecular diagnostics, and microbiology in Canadian hospital and reference lab channels.
• Cepheid (Danaher) Canada: Cepheid's GeneXpert molecular platform competes directly with BioFire FilmArray in Canadian hospitals for syndromic infectious disease testing. Both are owned by Danaher (Cepheid) and bioMérieux (BioFire) respectively, intensifying the competitive dynamic.

Emerging players

• QIAGEN Canada: QIAGEN Canada offers sample-prep and molecular testing solutions that complement or compete with parts of bioMérieux's molecular diagnostics portfolio. Smaller Canadian footprint than bioMérieux but relevant in molecular workflows.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/user/biomerieuxtv
• Facebookfacebook.com/biomerieux
• LinkedInlinkedin.com/company/biomerieux
• Instagraminstagram.com/life.at.biomerieux

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about bioMérieux Canada, Inc.